Proficio Capital Partners LLC bought a new stake in Corteva, Inc. (NYSE:CTVA – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 7,814 shares of the company’s stock, valued at approximately $662,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. Brighton Jones LLC raised its position in Corteva by 307.2% during the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after purchasing an additional 11,760 shares during the period. Woodline Partners LP grew its holdings in Corteva by 40.3% during the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock worth $3,645,000 after acquiring an additional 16,644 shares in the last quarter. EverSource Wealth Advisors LLC raised its position in shares of Corteva by 62.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock worth $191,000 after acquiring an additional 980 shares in the last quarter. Cresset Asset Management LLC boosted its holdings in shares of Corteva by 2.6% in the 2nd quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock valued at $526,000 after buying an additional 181 shares in the last quarter. Finally, Jump Financial LLC purchased a new position in Corteva in the second quarter worth $1,464,000. 81.54% of the stock is owned by institutional investors.
Corteva Stock Up 0.0%
CTVA opened at $83.08 on Thursday. The company has a market cap of $55.43 billion, a PE ratio of 55.02, a price-to-earnings-growth ratio of 2.55 and a beta of 0.57. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $90.97. The company has a 50-day moving average price of $82.51 and a 200 day moving average price of $80.45. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07.
Corteva Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s payout ratio is 47.68%.
Wall Street Analysts Forecast Growth
A number of equities analysts have issued reports on the stock. Mizuho raised their price target on shares of Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 14th. Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 11th. Weiss Ratings cut Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. Jefferies Financial Group upped their price objective on Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $101.00 price objective on shares of Corteva in a research note on Monday, August 3rd. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $91.50.
Get Our Latest Stock Analysis on CTVA
Corteva Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
See Also
- Five stocks we like better than Corteva
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
